Effects of dose-intensive chemotherapy and radiotherapy on serum n-terminal proatrial natriuretic peptide in high-risk breast cancer patients
Author:
Publisher
Springer Science and Business Media LLC
Subject
Cancer Research,Oncology
Link
http://www.springerlink.com/index/pdf/10.1023/A:1017946315032
Reference32 articles.
1. Gottdiener JS, Appelbaum FR, Ferrans VJ, Deisseroth A, Ziegler J: Cardiotoxicity associated with high-dose cyclophosphamide therapy. Arch Intern Med 141: 758-763, 1981
2. Von Hoff DD, Layard MW, Basa P, Davis HL, Von Hoff AL, Rozencweig M, Muggia FM: Risk factors for doxorubicininduced congestive heart failure. Ann Int Med 91: 710-717, 1979
3. Lipshultz SE, Colan SD, Gelber RD, Perez-Atayde AR, Sallan SE, Sanders SP: Late cardiac effects of doxorubic in therapy for acute lymphoblastic leukemia in childhood. N Engl J Med 324: 808-815, 1991
4. Steinherz LJ, Steinherz PG, Tan CTC, Heller G, Murphy L: Cardiac toxicity 4 to 20 years after completing anthracycline therapy. JAMA 266: 1672-1677, 1991
5. Robert NJ: Role of postmastectomy radiotherapy: A medical oncology perspective. Sem Rad Oncol 9: 241-246, 1999
Cited by 6 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. B-type natriuretic peptide plasma level in 5-year breast cancer survivors after radiotherapy;International Journal of Radiation Biology;2018-12-03
2. Kinetics of B-type natriuretic peptide plasma levels in patients with left-sided breast cancer treated with radiation therapy: Results after one-year follow-up;International Journal of Radiation Biology;2015-05-14
3. Timely Recognition of Cardiovascular Toxicity by Anticancer Agents: A Common Objective of the Pharmacologist, Oncologist and Cardiologist;Cardiovascular Toxicology;2011-09-06
4. Long-term follow-up of the SBG 9401 study comparing tailored FEC-based therapy versus marrow-supported high-dose therapy;Annals of Oncology;2007-04
5. Atrial natriuretic peptide and related peptides;Clinical Chemical Laboratory Medicine;2007-01-01
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3